Literature DB >> 10490532

Congenital nephrotic syndrome responsive to captopril and indometacin.

P A Heaton1, O Smales, W Wong.   

Abstract

Two children with congenital nephrotic syndrome are described (one with Finnish-type nephrosis, the other with diffuse mesangial sclerosis). Both children have had a prolonged and sustained clinical response with good physical health and normal growth patterns using captopril and indometacin as their sole treatment. No adverse effects have been noted. We recommend a trial of indometacin and captopril treatment in cases of congenital nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490532      PMCID: PMC1718016          DOI: 10.1136/adc.81.2.174

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population.

Authors:  A Fuchshuber; P Niaudet; O Gribouval; G Jean; M C Gubler; M Broyer; C Antignac
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

2.  Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type.

Authors:  R Birnbacher; E Förster; C Aufricht
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

3.  Adequate clinical control of congenital nephrotic syndrome by enalapril.

Authors:  S Guez; M Giani; M L Melzi; C Antignac; B M Assael
Journal:  Pediatr Nephrol       Date:  1998-02       Impact factor: 3.714

4.  Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.

Authors:  A Pomeranz; B Wolach; J Bernheim; Z Korzets; J Bernheim
Journal:  J Pediatr       Date:  1995-01       Impact factor: 4.406

Review 5.  Management of congenital nephrotic syndrome of the Finnish type.

Authors:  C Holmberg; M Antikainen; K Rönnholm; M Ala Houhala; H Jalanko
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  5 in total
  7 in total

1.  Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan.

Authors:  Yuko Hamasaki; Masaki Muramatsu; Riku Hamada; Kenji Ishikura; Hiroshi Hataya; Hiroyuki Satou; Masataka Honda; Koichi Nakanishi; Seiichiro Shishido
Journal:  Clin Exp Nephrol       Date:  2017-11-28       Impact factor: 2.801

2.  Management of congenital nephrotic syndrome.

Authors:  Larisa Kovacevic; Christopher J D Reid; Susan P A Rigden
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

3.  Nephrotic syndrome in infancy can spontaneously resolve.

Authors:  Jon Jin Kim; Joanna Clothier; Neil J Sebire; David V Milford; Nadeem Moghal; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2011-05-26       Impact factor: 3.714

4.  Glomerular structural factors in progression of congenital nephrotic syndrome.

Authors:  Abhay N Vats; Brian Costello; Michael Mauer
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

5.  Congenital nephrotic syndrome of the finnish type.

Authors:  Ev Badoe; R Kumoji
Journal:  Ghana Med J       Date:  2008-03

6.  Long-term outcome of heavy proteinuria in patients under 2 years of age.

Authors:  Jei-Wen Chang; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

7.  Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy.

Authors:  William Wong; Maxwell Clarke Morris; Tonya Kara
Journal:  Pediatr Nephrol       Date:  2013-08-15       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.